Equities

Evolent Health Inc

Evolent Health Inc

Actions
  • Price (EUR)12.80
  • Today's Change-10.20 / -44.35%
  • Shares traded1.87k
  • 1 Year change-50.00%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments193188266
Total Receivables, Net447255131
Total Inventory------
Prepaid expenses302151
Other current assets, total141476
Total current assets684478524
Property, plant & equipment, net90137132
Goodwill, net1,117723426
Intangibles, net752443280
Long term investments4.904.485.46
Note receivable - long term------
Other long term assets----0
Total assets2,6801,8171,419
LIABILITIES
Accounts payable485796
Accrued expenses216171166
Notes payable/short-term debt000
Current portion long-term debt/capital leases----0
Other current liabilities, total410205183
Total current liabilities674433445
Total long term debt597413216
Total debt597413216
Deferred income tax134.741.40
Minority interest------
Other liabilities, total15010763
Total liabilities1,434958726
SHAREHOLDERS EQUITY
Common stock1.151.020.91
Additional paid-in capital1,8081,4871,341
Retained earnings (accumulated deficit)(719)(606)(627)
Treasury stock - common(21)(21)(21)
Unrealized gain (loss)------
Other equity, total(1.26)(1.18)(0.36)
Total equity1,246859694
Total liabilities & shareholders' equity2,6801,8171,419
Total common shares outstanding11410089
Treasury shares - common primary issue1.541.541.54
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.